financetom
Business
financetom
/
Business
/
BRIEF-Sumitomo Mitsui Spokesperson Declines To Comment On Report Of Seven & I Management Buyout Deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Sumitomo Mitsui Spokesperson Declines To Comment On Report Of Seven & I Management Buyout Deal
Nov 12, 2024 7:36 PM

Nov 13 (Reuters) - Seven & i Holdings Co Ltd ( SVNDF ):

* SUMITOMO MITSUI SPOKESPERSON DECLINES TO COMMENT ON REPORT

OF

SEVEN & I MANAGEMENT BUYOUT DEAL

Source text:

Further company coverage:

(Reporting by Tokyo Newsroom)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sally Beauty Fiscal Q4 Non-GAAP Earnings, Revenue Rise; Fiscal Q1, Fiscal 2026 Guidance Issued
Sally Beauty Fiscal Q4 Non-GAAP Earnings, Revenue Rise; Fiscal Q1, Fiscal 2026 Guidance Issued
Nov 13, 2025
07:12 AM EST, 11/13/2025 (MT Newswires) -- Sally Beauty ( SBH ) reported Thursday fiscal Q4 non-GAAP earnings of $0.55 per diluted share, up from $0.50 per share a year earlier. Analysts surveyed by FactSet expected non-GAAP earnings of $0.48. Revenue for the quarter ended Sept. 30 was $947.1 million, up from $935 million a year earlier. Four analysts surveyed...
GoHealth Q3 revenue misses estimates on reduced Medicare Advantage volume
GoHealth Q3 revenue misses estimates on reduced Medicare Advantage volume
Nov 13, 2025
Overview * GoHealth Q3 2025 revenue declines 71% yr/yr, missing analyst expectations * Adjusted EBITDA for Q3 misses estimates, reflecting strategic pullback in Medicare Advantage * Company focuses on retention and quality amid changing Medicare market dynamics Outlook * Company secured superpriority term loan facility to enable strategic flexibility Result Drivers * MEDICARE ADVANTAGE PULLBACK - Co reduced Medicare Advantage...
Wind tower maker Broadwind tops Q3 revenue estimates, lifts guidance
Wind tower maker Broadwind tops Q3 revenue estimates, lifts guidance
Nov 13, 2025
Overview * Broadwind ( BWEN ) Q3 revenue grows 25% yr/yr, beating analyst expectations * Company reports GAAP net income of $7.5 mln for Q3 2025 * Broadwind ( BWEN ) raises full-year 2025 revenue guidance Outlook * Broadwind ( BWEN ) raises full-year 2025 revenue guidance to $155 mln-$160 mln * Company received $11 mln in new tower orders...
Applied Therapeutics Q3 net loss of $19 mln beats expectations
Applied Therapeutics Q3 net loss of $19 mln beats expectations
Nov 13, 2025
Overview * Applied Therapeutics ( APLT ) Q3 net loss of $19 mln beats analyst expectations * Company's Q3 operating income also beats analyst expectations * Research and development expenses decreased by $5.2 mln compared to Q3 2024 Outlook * Company to meet FDA in 4Q 2025 on govorestat for Classic Galactosemia * Company plans further FDA meeting for Phase...
Copyright 2023-2026 - www.financetom.com All Rights Reserved